[AF-FORUM] 161E 急诊和随后一天快室率房颤的控制 Dr. Vidal

[AF Symposium]

尊敬的Pereira医生

我想你的意思是给予患者抗凝治疗防止心房血栓形 
成，这样的处理和给予紧急心脏复律是相同的：注射 
肝素使KPTT达到基础数值两倍。

提及剂量（40毫克）的低分子肝素表现抗Xa作用，而 
肝素作为抗凝血酶药在阻止血栓事件发生起到了重要 
的作用。



肖明译 王玲洁校

161S A-Fib Tach RATE control in ER and the next day. Dr. Vidal
Dear Dr. Pereira,

I think that if your intention is to anticoagulate the patient to  
prevent embolism with atrial origin, the management should be the  
same as for emergency cardioversion: EV heparin to obtain a KPTT of  
twice the basal value.

  Low Molecular Weight Heparin behaves in the mentioned dose (40 mg)  
as anti-Xa, and EV heparin as anti-thrombin, which makes it an  
important agent to prevent embolic event.

Sincerely,



Dr. Oscar Vidal

Argentina La Plata



--
Dr. Sergio Dubner
President of Scientific Committee

Dr. Edgardo Schapachnik
President of Steering Committee